Antiarrhythmic drugs in the era of atrial fibrillation ablation.

Authors :: Boriani G
Mei DA
Imberti JF
Source :: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology [Europace] 2024 Jun 03; Vol. 26 (6).
Publication Year :: 2024
Abstract: Competing Interests: Conflict of interest: G.B. reported speaker fees of small amount from Bayer, Boston, Boehringer, Daiichi-Sankyo, Janssen, Sanofi, outside the submitted work. The other authors reported no conflict.

Subjects :: Humans
Treatment Outcome
Atrial Fibrillation surgery
Atrial Fibrillation drug therapy
Anti-Arrhythmia Agents therapeutic use
Catheter Ablation

Language :: English
ISSN :: 1532-2092
Volume :: 26
Issue :: 6
Database :: MEDLINE
Journal :: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Publication Type :: Academic Journal
Accession number :: 38700094
Full Text :: https://doi.org/10.1093/europace/euae122